Funding Opportunities

COVID-19 Response Funding Opportunities

Availability: Open

Closing Date: None. Apply at any time

Value: 80% of the full economic cost (fEC) for Research Council funding. For Innovate UK funding, State Aid rules apply.

Duration: Up to 18 months

Eligibility: You can apply for funding to research COVID-19 as part of normal UKRI funding streams and opportunities.

Summary: Proposals are invited for short-term projects addressing and mitigating the health, social, economic, cultural and environmental impacts of the Covid-19 outbreak. Researchers holding existing UKRI standard grants should in the first instance consider whether they could repurpose that funding to address the objectives of this call. You can apply to switch your existing grants.

Location: UK

Availability: Open

Closing Date: No closing date

Value: £80,000

Duration: 3 to 6 months

Eligibility: Applicants must be based at UK research organisations eligible for UKRI funding, demonstrate host organisation support for their proposal, meet the standard eligibility requirements for the council submitted to. Business-led proposals are not eligible for this funding. Business collaboration will be considered on a case by case basis. However, projects must be academic led and business collaboration is subject to the eligibility rules of each research council.

Summary: Apply for funding to support short term time-sensitive collection of data or samples or rapid turn-around research or analysis to either: inform urgent policy or national decision making; secure data for future research use.

All activities funded through this route must not overlap with UKRI’s portfolio of funded research.

Location: UK

Availability: Open

Closing Date: Not specified

Value: None – Accelerator

Duration: Not specified

Eligibility: For people who have a tech solution or innovative idea on how to address one or more of challenges created by COVID-19.

Summary: The partnership focus on ways that existing tech solutions can address the isolation of the vulnerable, reduce noncritical demand into the NHS and aid diagnostics and treatment. Looking for innovations that can slow the spread of COVID-19, enable home-based care, support the wellbeing and morale of NHS staff, and assist those who are most vulnerable and in self-isolation.

Location: UK

Other Funding Opportunities

Availability: Open

Closing Date: 31 May 2022

Value: Up to £30,000 per company.

Duration: Not specified

Eligibility: Applications must be from UK registered SME company.

Summary: The aim of this programme is to support small and medium-sized companies (SMEs) that are currently producing or are developing products in the medical technology (MedTech), health technology (HealthTech), diagnostics (including in-vitro diagnostics) and software as a medical device markets to access regulatory related advice and support. This is currently very pertinent as the UK and the EU have seen changes to medical device and in vitro diagnostic device regulations which will affect the UK industry. This project seeks to offer support to the UK health technology industry to mitigate these changes.

Companies can apply for grant funding for regulatory support up to £30,000. Regulatory support may include but is not limited to activities such as:

Global registrations
Mock audits
Quality
Clinical guidance pertaining to regulatory affairs
Technical guidance relating to standards
Guidance on MDR, IVDR, FDA
Advice on reimbursement models
Guidance on Technical File development
Contributions towards remedial action (for example electrical safety testing, biocompatibility testing etc)
Notified body costs.

You must demonstrate that you are developing, or currently selling, a medical device, health technology, IVD. etc (as defined in the section titled “Applicant”) and that you need regulatory support for activities such as those outlined in the section titled “Project Description”, which can be found in the Competition summary. If successful, you will receive grant funding of up to £30,000 that you can use to pay for the support received from a regulatory affairs support company. You and your provider must be able to complete this support by 5pm GMT on 19th August 2022.

Location: UK

Availability: Open

Closing Date: Not specified

Value: Up to £25,000 of initial funding

Duration: Not specified

Eligibility: Not specified

Summary: Scottish Health Innovations Ltd (SHIL) is seeking sustainable, forward-thinking ideas from health and social care professionals that can help support NHS Scotland to adapt, develop and strengthen in response to climate change. With NHS Scotland also committing to be a ‘net-zero’ greenhouse gas emissions organisation by 2045 at the latest, significant work is undoubtedly required. The behaviours of NHS Scotland’s 160,000-strong workforce will influence how the service mitigates and adapts to climate change impacts; and so, encouraging this diverse workforce to come up with new ways of working is vital and is at the heart of the latest Scottish Health Innovations Ltd (SHIL) innovation call.

Location: Scotland

Availability: Open

Closing Date: midnight on Friday 25 June 2022.

Value: £2,000 grant, one-to-one support, links to investors. The chance to win £5,000 on Demo Day. The opportunity to be part of the Bayes Centre.

Duration: 4 – month programme.

Eligibility: Pre-formation start-ups, early-stage businesses at proof-og-concept stage, teams or solo founders.

Summary: The Venture Builder Incubator is a 4-month programme which provides a framework of skills and knowledge required to validate the commercial potential of data-driven ideas.

Location: UK

Availability: Open

Closing Date: 27 May 2022

Value: £15,000

Duration: Not specified

Eligibility: SME’s and individuals working for either HEIs or NHS Trusts.

Summary: The competition invites applications for medical devices/ technologies addressing the prevention and/ or management of the psychological impact of traumatic physical injury. Any medical device-based solution for any psychological impact of traumatic physical injury will be considered.

The support includes, but is not limited to, the below:

Patient and Public Involvement members feedback
Expert review of the technology by relevant clinicians/service users
Formative usability study conducted in MD-TEC
Medical device regulatory support
Health economics work
Evidence generation to support NHS uptake of technology

Availability: Open

Closing Date: 26 May 2022.

Value: £5k and £10k per company with the chance to win additional funding (exact amount TBC)

Duration: 6 – month

Eligibility: AI-focused entrepreneurs and businesses scaling up from across the UK and the world can apply to take part in this 6-month Accelerator to benefit from the expertise and talent on offer in Edinburgh.

Summary: The next AI Accelerator programme will be focused around 3 key themes:

AI for climate change
AI for global health
AI for good

The AI Accelerator is delivered by The University of Edinburgh’s world-leading innovation hub for Data Science and Artificial Intelligence, the Bayes Centre, as part of the Bayes Centre DDE Innovation and Edinburgh Innovations, the University of Edinburgh’s commercialisation service. It gives data-driven scaleups the opportunity to harness the power of AI and bring about transformative change. From AgriTech to FinTech, AI technology can bring efficiencies, create new propositions and disrupt markets. It can help save lives and the planet.

The Accelerator is delivered in partnership with Edinburgh strategic design consultancy NileHQ and supported by Huawei UK.

Location: UK

Availability: Open

Closing Date: 18 May 2022

Value: £65,000

Duration: 15 – week technical support and business accelerator programme.

Eligibility: To all registered UK Businesses.

Summary: The Scotland 5G Centre’s inaugural innovation challenge hopes to bring new products and services into the supply chain, or closer to market realisation, to meet the needs of the health and social care community.

The Scotland 5G Centre and our partners have outlined 3 core challenges within the Scottish health and social care sector. We are looking for suitable fully registered UK companies to test and validate their digital solution in a stand-alone 5G environment.

This opportunity will allow your company the ability to test your product or service in a private 5G environment but most importantly provides the chance to develop your solution to ensure it is market ready and fit for purpose. It doesn’t stop here; winning companies will also be supported post challenge to exploit their solution in real world environments through the established challenge partner network. You will be working with a wide range of industry experts including 5G technical specialists AWTG and “go-to-market” and scaling advisors CGI. You will also receive 1.1 engagement, insight and knowledge from the challenge owners Dumfries & Galloway Health & Social Care Partnership and Scottish Care.

To apply, you will need to meet our criteria and complete the steps in the selection process. 3 winners will be selected and the innovation challenge will commence 27 June 2022. Companies applying for this challenge are expected to commit to the full programme of activity to maximise the opportunity and value of services being offered.

Availability: Open

Closing Date: Not specified

Value: Healthy Ageing Challenge -Total funding available under the programme includes £15.5 million of grant funding and £15.5 million of equity investment.
Funding for early-stage companies: £300K

Duration: Not specified

Eligibility: companies for whom prostate cancer is a primary target.

Summary: The charity’s mission is to create scientific breakthroughs by directing financial support, advice and collaboration opportunities that could have a meaningful impact on patients’ lives.

Its investment programme (Proven Connect) is dedicated to supporting companies developing:

innovative diagnostics
therapeutics
drug delivery systems
services that have the potential to transform the patient journey for men with prostate cancer.

It will focus on early-stage investments, including:

companies for whom prostate cancer is a primary target
companies with innovative technologies with potential applications in prostate cancer.

Availability: Open

Closing Date: 1 pm on 30 June 2022

Value: The upper grant award limit for these grants is £250,000 in total over one to three years.
The total amount available under the joint 2022 funding call for awards is £250,000.

Duration: 1-3 years.

Eligibility: Applications for joint funding must be from lead applicants with tenured posts at
recognised Scottish Universities, or NHS Board.

Summary: CSO is proud to be a partner in the Scottish Government / Wellbeing of Women funding call for Endometriosis Research. WoW-SG Research Project Grants are for projects in laboratory, health and translational research that aims to improve access for women to appropriate support, diagnosis and the best treatment for endometriosis.We are particularly encouraging applications in one of the following priority themes:

Can a cure be developed for endometriosis?
Is it possible to develop a non-invasive screening tool to aid the diagnosis of
endometriosis?
What is the most effective way of managing the emotional and/or psychological and/or fatigue impact of living with endometriosis (including medical, non-medical and self-management methods)

Location: Scotland

Availability: Open

Closing Date: 25 May 2022

Value: Your project’s total costs must be between £150,000 and £4 million. The total grant cannot exceed £2 million.

Duration: Not specified

Eligibility: Your project must:

have total project costs between £150,000 and £4 million
not exceed a grant request of £2 million
have at least 50% of the total project costs shared by the SMEs, if collaborative
start by 1 December 2022
end by 30 November 2025
last between 6 months and 36 months
carry out all of its project work in the UK
intend to exploit the results from or in the UK

Summary: Innovate UK, part of UK Research and Innovation will invest up to £15 million in projects to support UK registered businesses to develop innovative health or healthcare-focussed products, technologies and processes.

Your project can focus on:

disease prevention and proactive management of health and chronic conditions
earlier and better detection and diagnosis of disease, leading to better patient outcomes
tailored treatments that either change the underlying disease or offer potential cures
the development of digital health technologies

Location: UK

Availability: Open

Closing Date: No closing date

Value: We will fund 80% of the full economic costs of your project. Not specified

Duration: Not specified

Eligibility: Research grants are open to UK higher education institutions, research council institutes, UKRI-approved independent research organisations and NHS bodies with research capacity.

Summary: You can apply for support for high-quality engineering and physical sciences research in line with our healthcare technologies theme and strategy. Funding will cover research into chemistry, engineering, information and communications technologies, materials, mathematical sciences and physics that underpin healthcare.

Location: UK

Availability: Ongoing

Closing Date: None – apply at any time

Value: Part-funded grant.

Duration: 12-36 months

Eligibility: Aimed at partnerships between a UK-based business of any size or non-profit organisation, an academic organisation and a suitably-qualified graduate.

Summary: Aimed at improving business’ competitiveness and productivity through funded partnership with academics and researchers.

Location: UK

Availability: Ongoing

Closing Date: Shortlisting meetings happen every 3 months

Value: Up to £500K or £750K for collaborations

Duration: Usually 2 years, or 3 years for multidisciplinary collaborations

Eligibility: Researchers, individuals and teams from not-for profit and commercial organisations that can be any size, based anywhere in the world (apart from China).

Summary: For researchers who are developing healthcare innovations that could have a major and measurable impact on human health. Proposals should describe global burden of a disease, unmet healthcare need, and the impact of innovation in a patient population.

Location: UK

Availability: Due to a potential change in approach, the 5th Call has been suspended. The challenges will be reviewed to better match Scottish Government ambitions.

Closing Date: Currently working to explore and define potential Calls and their timelines.

Value: SBRI: £10k -£40k per supplier (Phase 1), £50k –200k per supplier (Phase 2); CivTech: £3k per supplier (Exploration Stage), £20k per supplier (Acceleration Stage)

Duration: Suspended

Eligibility: Scottish companies of any size and academic and third sector organisations who can demonstrate how they will commercialise solutions which they develop.

Summary: Funding to support the development of innovative solutions for challenges faced by a Scottish public body where there is no clear fix or current market solution.

Location: Scotland

Available Funding Opportunities

COVID-19 Response Funding Opportunities

Funding for COVID-19 research

UKRI

Expression of interest: emergency route for time-critical COVID-19 research

UK Research and Innovation

Barclays Healthtech Response

Barclay’s, The University of Edinburgh, UCL and CodeBase

Other Funding Opportunities

Health Technology Regulatory and Innovation Programme

Innovate UK

SHIL Sustainability Innovation Call

SHIL

DDE Venture Builder Incubator 3.0 Application

Mental Health Competition

Trauma Management MedTech Co-operative

The University of Edinburgh AI Accelerator

Shaping Digital Health & Social Care

The Scoltnad 5G Centre

Partnership funds diagnosis and treatments for prostate cancer

UK Research and Innovation

Scottish Government & Wellbeing of Women Funding Call for Endometriosis Research

Biomedical Catalyst 2022 Round 1: Industry-led R&D

Innovate UK

Healthcare Technologies Investigator-Led Grant

Engineering and Physical Sciences Research Council EPSRC

Knowledge Transfer Partnership

UK Government

Innovators Awards

Welcome Trust

Innovation Challenge Fund

Can Do (Scottish Enterprise)